The burden of metabolic risk factors in North Africa and the Middle East, 1990-2019: findings from the Global Burden of Disease Study

被引:9
|
作者
Malekpour, Mohammad-Reza [1 ]
Abbasi-Kangevari, Mohsen [1 ]
Ghamari, Seyyed-Hadi [1 ]
Khanali, Javad [1 ]
Heidari-Foroozan, Mahsa [1 ]
Moghaddam, Sahar Saeedi [1 ,2 ]
Azangou-Khyavy, Mohammadreza [1 ]
Rezazadeh-Khadem, Sahba [1 ]
Rezaei, Negar [1 ]
Shobeiri, Parnian [1 ]
Esfahani, Zahra [1 ]
Rezaei, Nazila [1 ]
Mokdad, Ali H. [3 ,4 ]
Naghavi, Mohsen [3 ,4 ]
Larijani, Bagher [5 ]
Farzadfar, Farshad [1 ,5 ]
机构
[1] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, Tehran, Iran
[2] Kiel Inst World Econ, Kiel, Germany
[3] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA USA
[4] Univ Washington, Sch Med, Dept Hlth Metr Sci, Seattle, WA USA
[5] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, Iran
关键词
Global burden of disease; Metabolic risk factors; High systolic blood pressure; High fasting plasma glucose; High body-mass index; High-LDL; North Africa and the Middle East; CARDIOVASCULAR RISK; PREVALENCE; HYPERTENSION; OVERWEIGHT; OBESITY; IRAQI;
D O I
10.1016/j.eclinm.2023.102022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The objective of this study is to investigate the trends of exposure and burden attributable to the four main metabolic risk factors, including high systolic blood pressure (SBP), high fasting plasma glucose (FPG), high body-mass index (BMI), and high low-density lipoproteins cholesterol (LDL) in North Africa and the Middle East from 1990 to 2019. Methods The data were retrieved from Global Burden of Disease Study 2019. Summary exposure value (SEV) was used for risk factor exposure. Burden attributable to each risk factor was incorporated in the population attributable fraction to estimate the total attributable deaths and disability-adjusted life-years (DALYs). Findings While age-standardized death rate (ASDR) attributable to high-LDL and high-SBP decreased by 26.5% (18.6-35.2) and 23.4% (15.9-31.5) over 1990-2019, respectively, high-BMI with 5.1% (-9.0-25.9) and high-FPG with 21.4% (7.0-37.4) change, grew in ASDR. Moreover, age-standardized DALY rate attributed to high-LDL and high-SBP declined by 30.2% (20.9-39.0) and 25.2% (16.8-33.9), respectively. The attributable age-standardized DALY rate of high-BMI with 8.3% (-6.5-28.8) and high-FPG with 27.0% (14.3-40.8) increase, had a growing trend. Age-standardized SEVs of high-FPG, high-BMI, high-SBP, and high-LDL increased by 92.4% (82.8-103.3), 76.0% (58.9-99.3), 10.4% (3.8-18.0), and 5.5% (4.3-7.1), respectively. Interpretation The burden attributed to high-SBP and high-LDL decreased during the 1990-2019 period in the region, while the attributable burden of high-FPG and high-BMI increased. Alarmingly, exposure to all four risk factors increased in the past three decades. There has been significant heterogeneity among the countries in the region regarding the trends of exposure and attributable burden. Urgent action is required at the individual, community, and national levels in terms of introducing effective strategies for prevention and treatment that account for local and socioeconomic factors. Funding Bill & Melinda Gates Foundation. Copyright & COPY; 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:13
相关论文
共 50 条
  • [1] The burden of prostate cancer in North Africa and Middle East, 1990-2019: Findings from the global burden of disease study
    Abbasi-Kangevari, Mohsen
    Moghaddam, Sahar Saeedi
    Ghamari, Seyyed-Hadi
    Azangou-Khyavy, Mohammadreza
    Malekpour, Mohammad-Reza
    Rezaei, Negar
    Rezaei, Nazila
    Kolahi, Ali-Asghar
    Amini, Erfan
    Mokdad, Ali H.
    Jamshidi, Hamidreza
    Naghavi, Mohsen
    Larijani, Bagher
    Farzadfar, Farshad
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [2] Burden of type 2 diabetes mellitus and its risk factors in North Africa and the Middle East, 1990-2019: findings from the Global Burden of Disease study 2019
    Namazi, Nazli
    Moghaddam, Sahar Saeedi
    Esmaeili, Shahnaz
    Peimani, Maryam
    Tehrani, Yeganeh Sharifnejad
    Bandarian, Fatemeh
    Shobeiri, Parnian
    Nasli-Esfahani, Ensieh
    Malekpour, Mohammad-Reza
    Rezaei, Negar
    Rezaei, Nazila
    Arjmand, Babak
    Larijani, Bagher
    Farzadfar, Farshad
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [3] Burden of type 1 diabetes mellitus in the North Africa and Middle East Region, 1990-2019; findings from the global burden of disease study
    Esmaeili, Shahnaz
    Moghaddam, Sahar Saeedi
    Namazi, Nazli
    Bandarian, Fatemeh
    Esfahani, Zahra
    Peimani, Maryam
    Shahin, Sarvenaz
    Nasli-Esfahani, Ensieh
    Akbarzadeh, Isa
    Ghanbari, Ali
    Rezaei, Negar
    Rezaei, Nazila
    Larijani, Bagher
    Farzadfar, Farshad
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 188
  • [4] The burden of Parkinson's disease in the Middle East and North Africa region, 1990-2019: results from the global burden of disease study 2019
    Safiri, Saeid
    Noori, Maryam
    Nejadghaderi, Seyed Aria
    Mousavi, Seyed Ehsan
    Sullman, Mark J. M.
    Araj-Khodaei, Mostafa
    Singh, Kuljit
    Kolahi, Ali-Asghar
    Gharagozli, Kurosh
    BMC PUBLIC HEALTH, 2023, 23 (01)
  • [5] Burden of breast cancer and attributable risk factors in the North Africa and Middle East region, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
    Azadnajafabad, Sina
    Moghaddam, Sahar Saeedi
    Mohammadi, Esmaeil
    Rezaei, Negar
    Rashidi, Mohammad-Mahdi
    Rezaei, Nazila H.
    Mokdad, Ali
    Naghavi, Mohsen
    Murray, Christopher J. L.
    Larijani, Bagher
    Farzadfar, Farshad
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [6] Infective Endocarditis in North Africa and the Middle East, 1990-2019: Updates from the Global Burden of Disease Study 2019
    Rad, Elaheh Malakan
    Momtazmanesh, Sara
    Moghaddam, Sahar Saeedi
    Rezaei, Nazila
    Jamshidi, Hamidreza
    Naghavi, Mohsen
    Larijani, Bagher
    Farzadfar, Farshad
    ARCHIVES OF IRANIAN MEDICINE, 2024, 27 (05) : 229 - 238
  • [7] Burden of type 2 diabetes mellitus and its risk factors in North Africa and the Middle East, 1990–2019: findings from the Global Burden of Disease study 2019
    Nazli Namazi
    Sahar Saeedi Moghaddam
    Shahnaz Esmaeili
    Maryam Peimani
    Yeganeh Sharifnejad Tehrani
    Fatemeh Bandarian
    Parnian Shobeiri
    Ensieh Nasli-Esfahani
    Mohammad-Reza Malekpour
    Negar Rezaei
    Nazila Rezaei
    Babak Arjmand
    Bagher Larijani
    Farshad Farzadfar
    BMC Public Health, 24
  • [8] Regional burden of chronic kidney disease in North Africa and Middle East during 1990-2019; Results from Global Burden of Disease study 2019
    Tabatabaei-Malazy, Ozra
    Moghaddam, Sahar Saeedi
    Khashayar, Patricia
    Keykhaei, Mohammad
    Tehrani, Yeganeh Sharifnejad
    Malekpour, Mohammad-Reza
    Esfahani, Zahra
    Rashidi, Mohammad-Mahdi
    Golestani, Ali
    Shobeiri, Parnian
    Moghimi, Mana
    Gorgani, Fateme
    Abdolhamidi, Elham
    Farzadfar, Farshad
    Larijani, Bagher
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [9] Burden of colorectal cancer and its risk factors in the North Africa and Middle East (NAME) region, 1990-2019: a systematic analysis of the global burden of disease study
    Haghighatdoost, Fahimeh
    Mehrabani-Zeinabad, Kamran
    Hajihashemi, Parisa
    Mohammadifard, Noushin
    Adibi, Peyman
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [10] Burden and Epidemiology of Mental Disorders in the Middle East and North Africa from 1990 to 2019: Findings from the Global Burden of Disease Study
    Effatpanah, Mohammad
    Nakhostin-Ansari, Amin
    Gorgani, Fateme
    Khotbehsara, Samaneh Tanhapour
    Seifi, Shakiba
    Nasoori, Hadis
    Memari, Amir Hossein
    Darijani, Seyed Reza
    BALKAN MEDICAL JOURNAL, 2024, 41 (02) : 121 - 129